Key Highlights
Datavault AI collaborates with Wellgistics to create $4B DelivMeds AI healthcare solution.
Platform merges blockchain technology, artificial intelligence, and pharmacy network infrastructure.
QOLPOM™ technology powers wearable devices and drone-based medication distribution systems.
Tollo Health investment incorporates telehealth services, specialized nutrition products, and AI wellness guidance.
Initial DelivMeds AI rollout begins in North Carolina before national healthcare expansion.
Datavault AI (DVLT) reached $0.4570 per share, climbing 1.20% following a fluctuating morning trading period. The organization completed a definitive partnership with Wellgistics Health (NASDAQ:WGRX). This collaboration seeks to establish DelivMeds AI, merging distributed ledger systems, machine learning, and medical service distribution.
The arrangement encompasses three simultaneous deals with a combined valuation approaching $4 billion. Datavault AI broadens its PharmacyChain™ licensing to incorporate Healthcare-as-a-Service proprietary technology. Additionally, the company secures QOLPOM™ intellectual property rights and majority ownership in Tollo Health, LLC.
DelivMeds AI will embed EinsteinRx AI capabilities within blockchain-secured smart contract frameworks. The system promises enhanced medication management, improved patient interaction, and optimized final-delivery pharmaceutical logistics. The nationwide deployment commences in North Carolina during July 2026.
PharmacyChain License Enhancement
Datavault AI extended PharmacyChain™ licensing to encompass Healthcare-as-a-Service innovations. The authorization now connects over 6,500 pharmaceutical outlets and 200 drug manufacturers across the country. EinsteinRx™ AI orchestrates qualification checks, enrollment procedures, and compliance monitoring on a massive scale.
The infrastructure additionally processes prior approval requests and direct-payment fulfillment operations seamlessly. Blockchain-based smart contracts guarantee protected, auditable prescription processing workflows. The framework supports machine learning-powered distribution networks and digital asset tokenization capabilities.
The American blockchain healthcare sector reached $7.13 billion in valuation during 2023. Industry forecasts predict expansion to $595.31 billion by 2032, representing a 63.5% compound annual growth rate. DelivMeds AI strategically positions Datavault to capitalize on this accelerating market transformation.
QOLPOM Technology Portfolio Integration
Datavault AI obtained QOLPOM™ intellectual property assets from EOS Technology and Scilex Holdings. This collection facilitates wearable-powered biometric authentication for individualized pharmaceutical dispensing. The suite features Data Driven Drones™ for medical product transport and specimen retrieval operations.
The innovation addresses adherence challenges and fraudulent activity vulnerabilities in medication distribution channels. It simultaneously enhances final-mile logistics in remote and medically underserved communities. QOLPOM™ technology elevates precision and security across telehealth and pharmacy operations.
Drone-facilitated medical supply delivery markets are anticipated to surge from $430 million in 2023 to $2.49 billion by 2032. DelivMeds AI harnesses this expansion trajectory to broaden patient accessibility nationwide.
Tollo Health Investment Strategy
Tollo Health contributes clinical expertise to DelivMeds AI via telemedicine infrastructure and AI-powered wellness counseling. The company provides therapeutic nutrition products addressing weight management, muscle deterioration, long COVID syndrome, and acute infectious diseases. The NFL Alumni Health collaboration establishes direct patient communication channels.
This acquisition reinforces DelivMeds’ consumer outreach capabilities and nationwide recognition profile. GLP-1 receptor agonist treatment markets, forecast to expand from $66 billion in 2025 to $185 billion in 2033, constitute a critical segment. The ecosystem combines nutritional supplement offerings with AI-facilitated behavioral health protocols.
All deals remain contingent upon standard due diligence procedures, board ratification, and finalization of binding contracts. DelivMeds AI unifies blockchain foundation, artificial intelligence capabilities, and nationwide pharmacy infrastructure. This initiative signifies a $4 billion commitment to revolutionizing patient-focused healthcare delivery systems.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
